CNBC June 13, 2025
Key Points
– Anne Wojcicki’s nonprofit will acquire substantially all of 23andMe’s assets for $305 million, the company announced Friday.
– 23andMe filed for Chapter 11 bankruptcy protection in March.
– Last month, Regeneron announced it would purchase most of 23andMe’s assets for $256 million, but it was outbid.
Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals, the company announced Friday.
TTAM will acquire substantially all of 23andMe’s assets for $305 million, including its Personal Genome Service and Research Services business lines as well as telehealth subsidiary Lemonaid Health. It’s a big win for Wojcicki, who stepped down from...
Today's Sponsors
Today's Sponsor